The 9 analysts offering 12-month price forecasts for Xenon Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 31.00 and a low estimate of 24.00. The median estimate represents a +56.42% increase from the last price of 17.90.
The current consensus among 9 polled investment analysts is to Buy stock in Xenon Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.35
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.